Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
19.2 HKD | +2.02% | +8.57% | -19.32% |
22/04 | Cansino Bio Gets Nod for China Clinical Trials of Haemophilus Influenzae Vaccine | MT |
22/04 | Cansino Biologics Pneumococcal Vaccine's Phase I Trial Offers Positive Results | MT |
Filters
- Stock Market
- Equities
- 6185 Stock
- News CanSino Biologics Inc.
- MarketScreener Editorial Features